Delivery Order SPE2DB22D2211-SPE2DB24FNLX5

Award Date 5/13/24
Potential Completion Date 5/14/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D6029|SPE2DB25FLUDP, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $16,519.86, is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $15,220.09, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRYCEL 70 MG TABLET 60S, a pharmaceutical product, with a performance period ending on July 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FF2VW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,157.79, is for the delivery of SPRYCEL 100 MG TABLET 30S, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at...
This federal contract award, SPE2DB22D3301|SPE2DB25FX4XZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $10,376.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 5, 2024. There is no set-aside designation for...
This federal contract award, with an ID of SPE2DB22D2009|SPE2DB25FL7HK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,974.93 delivery order contract is for the supply of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through January 15, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of SPRYCEL 140 MG TABLET 30S. The contract, valued at $43,344.24, is a Firm Fixed Price Delivery Order with a completion date of February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRYCEL 70 MG TABLET 60S, valued at $12,196.84. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, with an ID of SPE2DB22D1103|SPE2DB24FTGB6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $24,591.83 firm-fixed-price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB24FEG30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $54,354.04. The contract has an ultimate completion date of November 22, 2023 and is a firm fixed-price delivery order. The contract is not designated as a...
This federal contract award, identified as SPE2DB24D2100|SPE2DB25FBCSF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,680.54 firm-fixed-price delivery order is for the supply of SPRYCEL 20 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNLX5
    Delivery Order

This federal contract award, with an ID of SPE2DB22D2211|SPE2DB24FNLX5, was issued by the Defense Logistics Agency (DLA) and awarded to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of SPRYCEL 140 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,331.86 and a completion date of May 14, 2024.

The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The company has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 12:19 PM